5.855
0.09%
-0.005
Handel nachbörslich:
5.88
0.025
+0.43%
Finanzdaten der Abeona Therapeutics Inc-Aktie (ABEO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | 3.50 | - |
Operating Expenses
|
8.49%
14.33
|
13.21 | 11.33 | 14.05 | 12.04 |
Interest Income/Expense |
773.39%
0.952
|
0.109 | 0.105 | 0.103 | 0.101 |
Depreciation and Amortization |
0.00%
0.50
|
0.50 | 0.50 | 0.60 | 0.70 |
Operating Income/Loss |
8.49%
-14.33
|
-13.21 | -11.33 | -10.55 | -12.04 |
Nonoperating Income/Loss |
24.30%
0.162
|
0.214 | 0.111 | 2.215 | 0.403 |
Income/Loss From Continuing Operations Before Tax |
176.84%
-31.58
|
41.10 | -11.84 | 3.50 | -9.107 |
Income/Loss From Continuing Operations After Tax |
90.33%
-31.58
|
-16.59 | -11.84 | -16.65 | -9.107 |
Net Income/Loss
|
90.33%
-31.58
|
-16.59 | -11.84 | -16.65 | -9.107 |
Preferred Stock Dividends And Other Adjustments |
0.022
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1,800%
27.32
|
1.4379 | 24.80 | 18.02 | 16.90 |
Diluted Average Shares |
1,800%
27.32
|
1.4379 | 24.80 | 18.02 | -0.5538 |
Basic Earnings Per Share |
81.25%
-1.16
|
-0.64 | -0.48 | 0.92 | -0.54 |
Diluted Earnings Per Share |
81.25%
-1.16
|
-0.64 | -0.48 | 0.92 | 0.56 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
0.022
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):